IMMUCELL CORP /DE/
For the period ended Dec 31, 2025. Filed Mar 30, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 30, 2026
ICCC$10.22+4.3%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 11. Executive Compensation
Information regarding compensation paid to our executive officers is incorporated herein by reference to the section entitled “Executive Compensation”, in the Company's definitive Proxy Statement, which we intend to file with the SEC within120 days after* December 31, 2025*.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.